Technical Development for Pediatric Cardiovascular MRI
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT02892136|
Recruitment Status : Recruiting
First Posted : September 8, 2016
Last Update Posted : January 26, 2021
|Condition or disease|
|Congenital Heart Disease Cardiovascular Disease|
The purpose of this protocol is to allow development and testing of new MRI techniques suitable for evaluating patients with cardiovascular disease, congenital heart disease, fetal cardiac structure, function, and physiology, and other fetal organ analysis. Individuals referred to Children's National Medical Center for a clinically indicated cardiac MRI or cardiac catheterization by their primary referring cardiologist or obstetrician, and who are enrolled in this study may also undergo additional research imaging.
Since such technical development work often depends on preliminary studies in healthy volunteers, the protocol also recruits healthy subjects.
|Study Type :||Observational|
|Estimated Enrollment :||5000 participants|
|Official Title:||Technical Development for Pediatric Cardiovascular MRI|
|Study Start Date :||May 2013|
|Estimated Primary Completion Date :||May 2026|
|Estimated Study Completion Date :||December 2026|
- To evaluate innovative noninvasive MRI techniques suitable for evaluating pediatric patients with cardiovascular disease, congenital cardiac disease, and fetal organ analysis including cardiac structure, function, and physiology. [ Time Frame: through study completion, an average of 1 year ]
- Natural history of congenital heart disease [ Time Frame: through study completion, an average of 1 year ]A secondary objective of this protocol is to catalog results from MR imaging studies that can be used to describe the natural history of congenital heart disease and other cardiovascular diseases acquired in the young.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02892136
|Contact: Russell R Cross, M.D.||firstname.lastname@example.org|
|Contact: Laura Olivieri, M.D.||email@example.com|
|United States, District of Columbia|
|Children's National Health System||Recruiting|
|Washington, District of Columbia, United States, 20010|
|Contact: Russell R Cross, MD 202-476-2020 firstname.lastname@example.org|
|Contact: Laura Olivieri, MD 202-476-2020 email@example.com|
|Principal Investigator:||Russell R Cross, MD||Children's National Health Systems|